386 related articles for article (PubMed ID: 29467486)
1. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
Malcikova J; Tausch E; Rossi D; Sutton LA; Soussi T; Zenz T; Kater AP; Niemann CU; Gonzalez D; Davi F; Gonzalez Diaz M; Moreno C; Gaidano G; Stamatopoulos K; Rosenquist R; Stilgenbauer S; Ghia P; Pospisilova S;
Leukemia; 2018 May; 32(5):1070-1080. PubMed ID: 29467486
[TBL] [Abstract][Full Text] [Related]
2. TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing.
Minervini CF; Cumbo C; Orsini P; Brunetti C; Anelli L; Zagaria A; Minervini A; Casieri P; Coccaro N; Tota G; Impera L; Giordano A; Specchia G; Albano F
Diagn Pathol; 2016 Oct; 11(1):96. PubMed ID: 27724982
[TBL] [Abstract][Full Text] [Related]
3.
Campo E; Cymbalista F; Ghia P; Jäger U; Pospisilova S; Rosenquist R; Schuh A; Stilgenbauer S
Haematologica; 2018 Dec; 103(12):1956-1968. PubMed ID: 30442727
[TBL] [Abstract][Full Text] [Related]
4. Detection and Functional Analysis of TP53 Mutations in CLL.
Pavlova S; Smardova J; Tom N; Trbusek M
Methods Mol Biol; 2019; 1881():63-81. PubMed ID: 30350198
[TBL] [Abstract][Full Text] [Related]
5. [TP53 mutation analysis in chronic lymphocytic leukaemia].
Fésüs V; Marosvári D; Kajtár B; Király PA; Demeter J; Gurbity Pálfi T; Egyed M; Plander M; Farkas P; Mátrai Z; Matolcsy A; Bödör C
Orv Hetil; 2017 Feb; 158(6):220-228. PubMed ID: 28166664
[TBL] [Abstract][Full Text] [Related]
6. An extensive molecular cytogenetic characterization in high-risk chronic lymphocytic leukemia identifies karyotype aberrations and TP53 disruption as predictors of outcome and chemorefractoriness.
Rigolin GM; Formigaro L; Cavallari M; Quaglia FM; Lista E; Urso A; Guardalben E; Martinelli S; Saccenti E; Bassi C; Lupini L; Bardi MA; Volta E; Tammiso E; Melandri A; Negrini M; Cavazzini F; Cuneo A
Oncotarget; 2017 Apr; 8(17):28008-28020. PubMed ID: 28427204
[TBL] [Abstract][Full Text] [Related]
7. TP53 mutation analysis in chronic lymphocytic leukemia: comparison of different detection methods.
Kantorova B; Malcikova J; Smardova J; Pavlova S; Trbusek M; Tom N; Plevova K; Tichy B; Truong S; Diviskova E; Kotaskova J; Oltova A; Patten N; Brychtova Y; Doubek M; Mayer J; Pospisilova S
Tumour Biol; 2015 May; 36(5):3371-80. PubMed ID: 25527155
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of TP53 mutations with the AmpliChip p53 research test in chronic lymphocytic leukemia: correlation with clinical outcome and gene expression profiling.
Chiaretti S; Tavolaro S; Marinelli M; Messina M; Del Giudice I; Mauro FR; Santangelo S; Piciocchi A; Peragine N; Truong S; Patten N; Ghia EM; Torrente I; De Propris MS; Nanni M; Lawrence J; Guarini A; Foà R
Genes Chromosomes Cancer; 2011 Apr; 50(4):263-74. PubMed ID: 21319261
[TBL] [Abstract][Full Text] [Related]
9. Deep targeted sequencing of
Brieghel C; Kinalis S; Yde CW; Schmidt AY; Jønson L; Andersen MA; da Cunha-Bang C; Pedersen LB; Geisler CH; Nielsen FC; Niemann CU
Haematologica; 2019 Apr; 104(4):789-796. PubMed ID: 30514802
[TBL] [Abstract][Full Text] [Related]
10. Relevance of TP53 for CLL diagnostics.
Catherwood MA; Gonzalez D; Donaldson D; Clifford R; Mills K; Thornton P
J Clin Pathol; 2019 May; 72(5):343-346. PubMed ID: 30712002
[No Abstract] [Full Text] [Related]
11. TP53 aberrations in chronic lymphocytic leukemia.
Trbusek M; Malcikova J
Adv Exp Med Biol; 2013; 792():109-31. PubMed ID: 24014294
[TBL] [Abstract][Full Text] [Related]
12. TP53 mutation analysis in clinical practice: lessons from chronic lymphocytic leukemia.
Malcikova J; Pavlova S; Kozubik KS; Pospisilova S
Hum Mutat; 2014 Jun; 35(6):663-71. PubMed ID: 24415659
[TBL] [Abstract][Full Text] [Related]
13. TP53 codon 72 single nucleotide polymorphism in chronic lymphocytic leukemia.
Bilous NI; Abramenko IV; Chumak AA; Dyagil IS; Martіna ZV
Exp Oncol; 2014 Dec; 36(4):258-61. PubMed ID: 25537220
[TBL] [Abstract][Full Text] [Related]
14. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.
Malcikova J; Pavlova S; Baliakas P; Chatzikonstantinou T; Tausch E; Catherwood M; Rossi D; Soussi T; Tichy B; Kater AP; Niemann CU; Davi F; Gaidano G; Stilgenbauer S; Rosenquist R; Stamatopoulos K; Ghia P; Pospisilova S
Leukemia; 2024 May; ():. PubMed ID: 38755420
[TBL] [Abstract][Full Text] [Related]
15. Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations.
Rigolin GM; Saccenti E; Bassi C; Lupini L; Quaglia FM; Cavallari M; Martinelli S; Formigaro L; Lista E; Bardi MA; Volta E; Tammiso E; Melandri A; Urso A; Cavazzini F; Negrini M; Cuneo A
J Hematol Oncol; 2016 Sep; 9(1):88. PubMed ID: 27633522
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic techniques and therapeutic challenges in patients with TP53 dysfunctional chronic lymphocytic leukemia.
Best G; Thompson P; Tam CS
Leuk Lymphoma; 2012 Nov; 53(11):2105-15. PubMed ID: 22568511
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Chronic Lymphocytic Leukemia with TP53 Aberrations].
Lysák D; Schwarz J
Klin Onkol; 2015; 28 Suppl 3():3S39-44. PubMed ID: 26489500
[TBL] [Abstract][Full Text] [Related]
18. [Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part II. Trisomy 12 in B-cell chronic lymphocytic leukemia detected by fluorescence in situ hybridization].
Wasik-Szczepanek E; Rupniewska ZM; Koczkodaj D; Bojarska A
Pol Arch Med Wewn; 2003 Dec; 110(6):1431-8. PubMed ID: 15052938
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL.
Agathangelidis A; Chatzidimitriou A; Chatzikonstantinou T; Tresoldi C; Davis Z; Giudicelli V; Kossida S; Belessi C; Rosenquist R; Ghia P; Langerak AW; Davi F; Stamatopoulos K;
Leukemia; 2022 Aug; 36(8):1961-1968. PubMed ID: 35614318
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of subclonal TP53 mutations in chronic lymphocytic leukemia: A next generation sequencing retrospective study.
De Luca G; Cerruti G; Lastraioli S; Conte R; Ibatici A; Di Felice N; Morabito F; Monti P; Fronza G; Matis S; Colombo M; Fabris S; Ciarrocchi A; Neri A; Menichini P; Ferrarini M; Nozza P; Fais F; Cutrona G; Dono M
Hematol Oncol; 2022 Dec; 40(5):962-975. PubMed ID: 35961859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
